氧化低密度脂蛋白预测轻型卒中或短暂性脑缺血发作患者的复发性卒中
在CHANCE试验中,对3019例轻型卒中或TIA患者基线血浆氧化低密度脂蛋白(oxLDL)水平进行盲法测定,主要结局为90天内任何卒中。校正传统混杂因素后,oxLDL最高四分位组(≥28.81 μg/dL)相比最低四分位组(<6.65 μg/dL)90天内复发性卒中风险更高(HR 1.43,95%CI 1.03-1.98)。oxLDL与各结局风险呈J形关联,且与低密度脂蛋白及双联抗血小板、降压、降糖、他汀类药物使用无显著交互作用。
要点
- 在轻型卒中或TIA患者中,校正传统混杂因素后,oxLDL最高四分位组(≥28.81 μg/dL)相比最低四分位组(<6.65 μg/dL)90天内复发性卒中风险更高(HR 1.43,95%CI 1.03-1.98)。
- oxLDL与各结局风险呈J形关联,且与低密度脂蛋白及双联抗血小板、降压、降糖、他汀类药物使用无显著交互作用。
- oxLDL升高可独立预测轻型卒中或TIA患者的复发性卒中。
核心结论
- oxLDL升高可独立预测轻型卒中或TIA患者的复发性卒中。
研究设计与样本
- 基于CHANCE试验,对3019例轻型卒中或TIA患者的基线血浆oxLDL水平进行盲法测定,核心实验室采用4E6抗体检测。
- 采用Cox比例风险模型分析oxLDL与复发性卒中的关联。
主要发现
- 3019例患者中,oxLDL中位数(四分位距)为13.96(6.65-28.81)μg/dL。
- 校正传统混杂因素后,oxLDL最高四分位组(≥28.81 μg/dL)相比最低四分位组(<6.65 μg/dL)90天内复发性卒中风险更高(HR 1.43,95%CI 1.03-1.98)。
- 次要结局结果相似,oxLDL与各结局风险呈J形关联。
- oxLDL与低密度脂蛋白及双联抗血小板、降压、降糖、他汀类药物使用无显著交互作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between oxidized low-density lipoprotein (oxLDL) and recurrent stroke in patients with minor stroke or TIA. METHODS: In the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) trial, baseline oxLDL levels were blindly measured in plasma with the 4E6 antibody in the core laboratory. The primary outcome was any stroke within 90 days. The secondary outcomes included any stroke within 1 year and ischemic stroke and combined vascular events within 90 days and 1 year. The associations of oxLDL with recurrent stroke were analyzed by Cox proportional hazards. RESULTS: Among 3,019 patients included in this study, the median (interquartile range) of oxLDL was 13.96 (6.65-28.81) μg/dL. After adjustment for conventional confounding factors, patients in the highest oxLDL quartile (≥28.81 μg/dL) had a higher risk of recurrent stroke within 90 days (hazard ratio 1.43, 95% confidence interval 1.03-1.98) compared to those in the lowest oxLDL quartile (<6.65 μg/dL). Similar results were found for secondary outcomes. We also found a J-shaped association between oxLDL and risk of each outcome. There were no significant interactions between oxLDL and low-density lipoprotein and use of dual antiplatelet, antihypertensive, antidiabetic, and statins agents. CONCLUSIONS: Elevated oxLDL levels can independently predict recurrent stroke in patients with minor stroke or TIA. CLINICALTRIALSGOV IDENTIFIER: NCT00979589.
引用
- Wang A, Xu J, Chen G, et al. Oxidized low-density lipoprotein predicts recurrent stroke in patients with minor stroke or TIA. Neurology. 2018. PMID: 30089614. doi:10.1212/WNL.0000000000006118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。